May 28, 2024
Providers | Tea Leaves
  • The demand for new weight-loss drugs like Novo Nordisk’s Ozempic and Wegovy is rapidly increasing among Americans, but there’s a shortage of health care providers trained in obesity care to meet this demand. This shortage raises concerns about the potential for errors in prescribing these medications and the lack of proper monitoring and support for patients experiencing side effects. While online platforms make it easier for patients to access these drugs, many doctors, including primary care physicians and pediatricians, lack sufficient training in obesity care. The limited availability of trained specialists poses challenges in managing severe cases of obesity and associated conditions. Efforts to improve obesity education and training for health care providers are underway, but significant gaps remain in addressing the growing burden of obesity in the United States. (Article here)